Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
These Cold and Flu Medicines Contain Phenylephrine, the Ingredient the FDA Plans to Ban
Phenylephrine is a medication that’s been used to relieve nasal congestion caused by colds, allergies, and hay fever, per the U.S. National Library of Medicine.
FDA to Finally Ban Controversial Ingredient in Popular Decongestants
Sudafed, Mucinex, Benadryl, Advil, Tylenol, Vicks, and Dimetapp. These popular brand names appear on oral decongestants that are staples of the cold and flu aisle in American drug stores, and yet many contain an ingredient that does not work as promised.
A Popular Decongestant Doesn’t Work. The FDA Is Finally Doing Something About It
Oral phenylephrine was shown to be ineffective for treating nasal congestion over a year go. This week, the FDA took the first steps toward removing it from pharmacy shelves.
FDA to pull common but ineffective cold medicine from market
The FDA says oral phenylephrine, used in many over-the-counter cough and cold medicines, "is not effective as a nasal decongestant."
FDA Wants To Pull Popular OTC Decongestant Used For Common Cold Over Effectiveness Concerns
On Thursday, the FDA proposed removing oral phenylephrine from the list of approved active ingredients for over-the-counter (OTC) nasal decongestants, citing concerns over its effectiveness. After reviewing available data,
Does Phenylephrine Work? Effective Alternatives as FDA Moves to Ban Ingredient in OTC Decongestants
Common decongestants may soon be pulled from shelves. The Food and Drug Administration (FDA) announced Wednesday its proposal to halt use of oral phenylephrine, an ingredient found in many cough and cold medicines,
FiercePharma
1d
FDA rejects Intercept's ask for Ocaliva full nod in rare liver disease, but accelerated approval remains
In the wake of an unfavorable advisory committee meeting in September, Intercept Pharmaceuticals’ bid to win full approval ...
6d
FDA moves to pull popular decongestant from shelves amid effectiveness concerns
The US Food and Drug Administration announced a proposal to remove oral phenylephrine – a common ingredient in many popular ...
MedPage Today
2d
FDA Rejects Full Approval of Liver Disease Drug
said during the
advisory
committee meeting in September. "Design a real study, do a real study, then we can talk about the ...
JD Supra
16h
Inaugural Meeting for FDA's Digital Health Advisory Committee to Focus on GenAI-enabled Medical Devices
The U.S. Food and Drug Administration's ("FDA") new advisory committee on digital health is set to examine its approach for evaluating and ...
FiercePharma
12d
In FDA adcomm, Lexicon gets another thumbs down for type 1 diabetes hopeful Zynquista
On Halloween, Lexicon was haunted again as an FDA advisory committee voted 11-3 to reject Zynquista as an accompanying ...
6d
on MSN
FDA proposes removing ineffective decongestant found in most cold medicine
FDA
officials said an agency review of the available data found oral phenylephrine is not effective as a nasal decongestant ...
The Pharma Letter
1d
FDA slaps CRL on Ocaliva sNDA
Intercept Pharmaceuticals, now wholly owned subsidiary of Italy’s Alfasigma, today revealed that the US Food and Drug ...
16h
About 100 decongestant lawsuits claiming bogus ingredient tossed
A New York federal judge on Tuesday dismissed about 100 lawsuits that claimed Procter & Gamble , Haleon and other companies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback